Dimitrios Boumpas

Oscillometric, greyscale- and novel color-Doppler-ultrasound indices of macrovascular damage in Sjögren’s: the SICARD cohort study

Konstantinos Triantafyllias, Mirjam Bach, Sebastian Bögel, Muthuraman Muthuraman et autres

BACKGROUND: To assess for the first time a combination of oscillometric, greyscale- and novel color-Doppler ultrasound (US) indices of carotid and aortic damage in patients with primary Sjögren's syndrome (pSS). Moreover, to examine associations of these markers with patient and disease-characteristics, as …

de, us, gr (code pays fourni par la source)

POS0960 LONG TERM MORTALITY OF PATIENTS WITH GIANT CELL ARTERITIS: CAUSES AND PREDICTORS IN A LARGE CONTEMPORARY PATIENT COHORT

M. Nitsa, Christina Tsalapaki, A. Lazarini, E. Argyriou et autres

Background: There are limited data on the long-term mortality rates, its causes and predictors in patients with giant cell arteritis (GCA). Objectives: To evaluate the long-term mortality rate, causes of death, and its predictors in a real-world GCA patient cohort. Methods: Multicenter, …

gr (code pays fourni par la source)

ABS0416 PERSISTENT-RELAPSING SARS-CoV-2 INFECTION FOLLOWING RITUXIMAB TREATMENT FOR AUTOIMMUNE RHEUMATIC DISEASES: NATURAL HISTORY AND IMPLICATIONS FOR MANAGEMENT

Katerina Chavatza, M.E. Antonogiannaki, Elisavet Mastrostamati, Charalampos Charalampidis et autres

Background: COVID-19 infection may persist or relapse in rheumatic patients under treatment with rituximab (RTX), leading to persistent detection by PCR of SARS-CoV-2 virus for protracted periods [1]. Objectives: To examine the rates and outcomes of persistent-relapsing COVID-19 (prCOVID-19) infection in patients …

gr (code pays fourni par la source)

Integrating carotid Doppler, greyscale US, and aortic oscillometry to evaluate macroangiopathy in myositides: the MYOCARD cohort

Konstantinos Triantafyllias, George Βertsias, Dimitrios Boumpas, Rebecca Hasseli et autres

OBJECTIVES: To evaluate the combination of novel colour Doppler US (CDUS), greyscale US (GSUS), and oscillometric indices of macroangiopathy in patients with idiopathic inflammatory myopathies (IIM). Second, to explore the associations between these imaging markers and both patient-related and disease-related characteristics, as …

de, gr, it, ch (code pays fourni par la source)

Anifrolumab for systemic lupus erythematosus with multi-refractory skin disease: A case series of 18 patients

Sofia Flouda, Evgenia Emmanouilidou, Αναστάσιος Καραμανάκος, Dimitra Koumaki et autres

Objective Skin involvement is common in systemic lupus erythematosus (SLE), but may be resistant to conventional treatment. We sought to evaluate the efficacy of anifrolumab (ANI) in refractory cutaneous manifestations of SLE. Methods Case series of patients with refractory cutaneous SLE from …

gr (code pays fourni par la source)

POS0165 MACHINE LEARNING-BASED APPROACHES TOWARDS STRATIFICATION OF DISEASE SEVERITY AND ORGAN DAMAGE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Panagiotis Garantziotis, D. Nikolopoulos, C. Adamichou, A. Fanouriakis et autres

gr, de, se (code pays fourni par la source)

AB1319 RATES AND FACTORS ASSOCIATED WITH THERAPY DISCONTINUATION IN A MULTICENTER COHORT OF PATIENTS WITH GIANT CELL ARTERITIS FOLLOWED FOR 7 YEARS

M. Nitsa, Christina Tsalapaki, A. Lazarini, E. Argyriou et autres

gr (code pays fourni par la source)

The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDS

Ioannis Grigoropoulos, Georgios Tsioulos, Artemis Kastrissianakis, Shiran Shapira et autres

Abstract Introduction EXO-CD24 are exosomes genetically manipulated to over-express Cluster of Differentiation (CD) 24. It consists of two breakthrough technologies: CD24, the drug, as a novel immunomodulator that is smarter than steroids without any side effects, and exosomes as the ideal natural …

gr, il, ie, gb (code pays fourni par la source)

Transcriptome Analysis to Decipher the Molecular Underpinnings of Response to Treatment in Systemic Lupus Erythematosus

Panagiotis Garantziotis, Georgia-Savina Moysidou, Noemin Kapsala, Sofia Flouda et autres

de, gr (code pays fourni par la source)

Moderate to Severe Osteoarthritis: What is the Economic Burden for Patients and the Health Care System? Insights from the “PONOS” Study

Paraskevi Savvari, Ioannis Skiadas, Myrto Barmpouni, Stamatios A Papadakis et autres

OBJECTIVE: To assess the economic burden of moderate to severe osteoarthritis (OA) management for patients and the health care system in Greece. DESIGN: A noninterventional, cross-sectional, prospective, epidemiological analysis of data from the medical records of patients with moderate to severe OA, …

gr (code pays fourni par la source)

PB1367 Pilot Study of microRNA (mir148a) Identification as a Biomarker for Early Diagnosis and Treatment of Heparin Induced Thrombocytopenia (HIT)

E. Kourepini, Giannoula Soufla, E. Iliopoulou, S. Georgantis et autres

Comparison of effectiveness between baricitinib and tocilizumab in severe COVID-19. A retrospective study.

Ioannis Tomos, Ioannis Grigoropoulos, Chrysavgi Kosti, Serafeim Chrysikos et autres

Immunomodulators including tocilizumab and baricitinib have been used for the treatment of severe COVID-19, however, studies comparing their efficacy are lacking. We aimed to compare their safety and effectiveness in severe COVID-19. Methods: All consecutive non-ICU hospitalized severe COVID-19 patients, from May …

gr (code pays fourni par la source)